HSR25-180: Real-World (rw) Characteristics, Treatment (tx) Patterns and Clinical Outcomes in Patients (pts) With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Received Chemoradiotherapy (CRT)
"HSR25-180: Real-World (rw) Characteristics, Treatment (tx) Patterns and Clinical Outcomes in Patients (pts) With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Received Chemoradiotherapy (CRT)" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Puneeth Iyengar (ORCID: https://orcid.org/0000-0003-3740-7915)
- Anne C. Chiang (ORCID: https://orcid.org/0000-0002-2111-4694)
- Natalia Donner (ORCID: https://orcid.org/0000-0003-4181-5102)
- Daniel Simmons (ORCID: https://orcid.org/0000-0002-3861-621X)
- Doreen A. Kahangire
- Kristin Hsieh (ORCID: https://orcid.org/0000-0003-4100-473X)
- Alice Wang (ORCID: https://orcid.org/0000-0003-4468-9367)
- Iqra Syed
Institutions
- AstraZeneca (United Kingdom) (GB)
- Memorial Sloan Kettering Cancer Center (US)
- Yale University (US)
- AstraZeneca (Canada) (CA)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7262
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00